Aliases & Classifications for Synovitis

About this section

Summaries for Synovitis

About this section
Disease Ontology:11 A connective tissue disease that results in inflammation located in synovial membrane that lines a synovial joint which causes pain and swelling.

MalaCards based summary: Synovitis is related to camptodactyly-arthropathy-coxa vara-pericarditis syndrome and tuberculosis, and has symptoms including arthralgia, arthralgia and metatarsalgia. An important gene associated with Synovitis is TNF (Tumor Necrosis Factor), and among its related pathways are Interleukin-1 processing and Antifolate resistance. Affiliated tissues include synovial membrane, bone and t cells, and related mouse phenotypes are integument and skeleton.

Wikipedia:71 Synovitis is the medical term for inflammation of the synovial membrane. This membrane lines joints that... more...

Related Diseases for Synovitis

About this section

Diseases related to Synovitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 379)
idRelated DiseaseScoreTop Affiliating Genes
1camptodactyly-arthropathy-coxa vara-pericarditis syndrome31.2CRP, CXCL8, ICAM1, IL1B, IL6, TNF
2tuberculosis30.0IL1B, IL6, TNF
3neuropathy29.6CRP, CXCL8, IL1B, IL6, TNF
4peroneal neuropathy29.3CRP, IL1B, IL6, TNF
5rheumatoid arthritis28.8COMP, CRP, CXCL8, ICAM1, IL18, IL1B
6osteonecrosis28.1COMP, CRP, CXCL8, IL1B, IL6, MMP1
7pigmented villonodular synovitis12.4
8villonodular synovitis12.3
9gonococcal synovitis11.9
10talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals11.8
11sapho syndrome11.8
12noonan syndrome 111.4
13intermittent hydrarthrosis11.1
14legg-calve-perthes disease11.1
15eosinophilic fasciitis11.1
16blau syndrome10.9
17noonan syndrome 410.8
18sarcoidosis, early-onset10.7
19arthritis10.6
20intussusception10.4IL1B, TNF
21symmastia10.4MMP1, MMP3
22acne10.3
23hyperostosis10.3
24idiopathic corneal edema10.3IL1B, MMP1, MMP3
25tau syndrome10.3IL18, IL1B, TNF
26amyotrophic lateral sclerosis type 1410.3CXCL8, IL1B, TNF
27parkinson disease 1110.3CXCL8, IL1B, TNF
28osteoarthritis10.3
29ovarian cystic teratoma10.3CXCL8, IL1B, TNF
30nasal cavity inverting papilloma10.3CXCL8, MMP13, TNFSF11
31bone resorption disease10.2IL1B, MMP13, MMP3
32spastic hemiplegia10.2ICAM1, MMP1, TNFSF11
33glucose intolerance10.2CXCL8, IL18, TNF
34cataract10.2CRP, IL1B, TNF
35vps11-related autosomal recessive hypomyelinating leukodystrophy10.2IL6, TNF
36phka2-related phosphorylase kinase deficiency10.2TNFRSF11B, TNFSF11
37pasteurellosis10.2IL6, MMP1, MMP3
38lymphedema10.2ICAM1, IL1B, VCAM1
39anal paget's disease10.2IL1B, IL6, TNF
40bipolar i disorder10.2IL1B, IL6, TNF
41oculomotor nerve paralysis10.2CXCL8, IL1B, IL6
42cerebrum cancer10.2CRP, IL1B, VCAM1
43pyloric stenosis, infantile hypertrophic, 210.2CRP, IL1B, TNF
44common peroneal nerve lesion10.2CXCL8, IL1B, IL6
45tinea capitis10.2IL1B, IL6, TNF
46measles10.2IL1B, IL6, TNF
47appendiceal l-cell glucagon-like peptide producing tumor10.2CRP, CXCL8, MMP3
48hidradenitis10.2CRP, CXCL8, IL1B
49perrault syndrome10.2ICAM1, MMP1, VCAM1
50hypoparathyroidism-retardation-dysmorphism syndrome10.2IL1B, IL6, TNF

Graphical network of the top 20 diseases related to Synovitis:



Diseases related to synovitis

Symptoms & Phenotypes for Synovitis

About this section

UMLS symptoms related to Synovitis:


arthralgia, metatarsalgia, myalgia

MGI Mouse Phenotypes related to Synovitis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107717.9ICAM1, IL18, IL1B, IL1RN, IL6, MMP13
2MP:00053907.8COMP, IL1B, IL1RN, IL6, MMP13, MMP3
3MP:00053976.8CD163, ICAM1, IL18, IL1B, IL1RN, IL6
4MP:00053856.5CD163, COMP, CRP, ICAM1, IL18, IL1B
5MP:00053766.3CD163, COMP, CRP, ICAM1, IL18, IL1B
6MP:00053876.1CD163, COMP, CRP, ICAM1, IL18, IL1B

Drugs & Therapeutics for Synovitis

About this section

Drugs for Synovitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 167)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Prednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2, Early Phase 1119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
2
MethotrexateapprovedPhase 4, Phase 3, Phase 215511959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
3
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2, Early Phase 1119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
4
InfliximabapprovedPhase 4, Phase 2392170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
5
Etanerceptapproved, investigationalPhase 4, Phase 3, Phase 2403185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
6
Bevacizumabapproved, investigationalPhase 42020216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
7
Certolizumab pegolapprovedPhase 4, Phase 3127428863-50-7
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
 
Certolizumab pegol (USAN/INN)
Certolizumab pegol (genetical recombination)
Certolizumab pegol (genetical recombination) (JAN)
D03441
cimzia
8
Apremilastapproved, investigationalPhase 4, Phase 275608141-41-911561674
Synonyms:
Apremilast
Apremilast (USAN)
Apremilastum
Aprémilast
CC-10004
 
CHEBI:558773
CHEMBL514800
CID11561674
D08860
N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide
N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
9
AdalimumabapprovedPhase 4, Phase 2494331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
10
rituximabapprovedPhase 4, Phase 3, Phase 21692174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
11
Leflunomideapproved, investigationalPhase 4, Phase 36775706-12-63899
Synonyms:
210165-51-8
4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl
4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl)
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide
5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)
5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide
5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
75706-12-6
A77 1486
AB00052389
AC-6796
AC1L1GYK
AC1Q2EVA
AKOS000265193
AP-501/42475599
Arava
Arava (TN)
Arava, Leflunomide
Aventis Behring Brand of Leflunomide
Aventis Brand of Leflunomide
Aventis Pharma Brand of Leflunomide
BIDD:PXR0189
BPBio1_000930
BRD-K78692225-001-03-9
BSPBio_000844
C045463
C07905
CAS-75706-12-6
CHEBI:6402
CHEMBL960
CID3899
D00749
DB01097
DivK1c_000916
EU-0100649
HMS1570K06
HMS1922M06
HMS2090O12
HMS502N18
HSDB 7289
HWA 486
HWA-486
Hoechst Brand of Leflunomide
I06-2131
IDI1_000916
KBio1_000916
KBio2_000802
KBio2_003370
KBio2_005938
KBioSS_000802
L 5025
L5025_SIGMA
 
LS-86580
Leflunomid
Leflunomida
Leflunomida [INN-Spanish]
Leflunomide
Leflunomide (JAN/USAN/INN)
Leflunomide [USAN:INN]
Leflunomidum
Leflunomidum [INN-Latin]
Lefunomide
Lefunomide [INN-Spanish]
Lefunomide [Inn-Spanish]
Lopac-L-5025
Lopac0_000649
MLS-0003109.0001
MLS000069648
MLS001076267
MolPort-002-345-613
N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
NCGC00015610-01
NCGC00015610-02
NCGC00015610-03
NCGC00015610-07
NCGC00015610-12
NCGC00022625-03
NCGC00022625-04
NCGC00022625-05
NCGC00022625-06
NCGC00022625-07
NCGC00022625-08
NINDS_000916
NSC677411
Prestwick0_000772
Prestwick1_000772
Prestwick2_000772
Prestwick3_000772
Prestwick_87
RS-34821
S1247_Selleck
SMR000058209
SPBio_002783
SPECTRUM1503927
SU 101
SU 101 (pharmaceutical)
SU-101
SU101
Spectrum5_000850
Spectrum_000322
TL8005179
UNII-G162GK9U4W
ZINC00004840
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
leflunomide
lefunamide
12
HydroxychloroquineapprovedPhase 4, Phase 2154118-42-33652
Synonyms:
(+-)-Hydroxychloroquine
(±)-hydroxychloroquine
118-42-3
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
747-36-4 (sulfate (1:1) salt)
AC1L1GEW
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
EINECS 204-249-8
Gen-Hydroxychloroquine 200mg Tablets
HCQ
HMS502P04
Hidroxicloroquina
 
Hidroxicloroquina [INN-Spanish]
Hydroxychlorochin
Hydroxychloroguine
Hydroxychloroquine (INN)
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquine [INN:BAN]
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
ST072188
Spectrum2_001238
Spectrum5_001697
UNII-4QWG6N8QKH
WIN 1258
hydroxychloroquine
13
Triamcinoloneapproved, vet_approvedPhase 4, Phase 2510124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
14
SulfasalazineapprovedPhase 460599-79-15353980, 5359476
Synonyms:
13gs
2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid
2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid
2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid
2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid
2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid
4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene
5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid
5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid
5-22-08-00433 (Beilstein Handbook Reference)
5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid
5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid
5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid
5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid
599-79-1
AC-20497
AC1NS4RK
AC1NSE0P
AC1NTMDP
AC1Q72VB
AKOS002311709
Accucol
Alphapharm Brand of Sulfasalazine
Alti-Sulfasalazine
Ashbourne Brand of Sulfasalazine
Asulfidine
Azlufidine EN-Tabs
Azopyrin
Azopyrine
Azosulfidin
Azulfadine
Azulfidine
Azulfidine (TN)
Azulfidine EN
Azulfidine EN-Tabs
Azulfidine EN-tabs
BIDD:GT0161
BPBio1_000527
BRD-K10670311-001-06-4
BRN 0356241
BSPBio_000479
BSPBio_002888
Benzosulfa
C07316
C18H14N4O5S
CAS-599-79-1
CCRIS 4713
CHEBI:45504
CHEBI:489907
CHEBI:9334
CHEMBL242373
CHEMBL421
CID5353980
CID5359476
CID5384001
CPD000059146
Colo Pleon
Colo-Pleon
D00448
D012460
DB00795
DB08518
DivK1c_000860
EINECS 209-974-3
EN, Azulfidine
FNA Brand of Sulfasalazine
HMS1569H21
HMS1921C05
HMS2051J21
HMS2090P13
HMS2092K07
HMS502K22
HSDB 3395
Henning Berlin Brand of Sulfasalazine
Heyl Brand of Sulfasalazine
I06-0676
IDI1_000860
KBio1_000860
KBio2_001478
KBio2_002314
KBio2_004046
KBio2_004882
KBio2_006614
KBio2_007450
KBio3_002108
KBio3_002794
KBioGR_000753
KBioGR_002314
KBioSS_001478
 
KBioSS_002316
LS-46
MLS000759399
MLS001424109
MolPort-001-792-507
MolPort-003-986-992
NCGC00016518-01
NCGC00090903-01
NCGC00090903-02
NCGC00090903-03
NCGC00090903-04
NCGC00090903-05
NINDS_000860
NSC 203730
NSC 667219
NSC203730
NSC667219
PMS-Sulfasalazine
Pfizer Brand of Sulfasalazine
Pleon
Pms-Sulfasalazine E.C.
Prestwick0_000520
Prestwick1_000520
Prestwick2_000520
Prestwick3_000520
Prestwick_848
Pyralin EN
Ratiopharm Brand of Sulfasalazine
Reupirin
Rorasul
S.A.S. 500
S.A.S. Enteric-500
S.A.S.-500
S0580
SAM001246530
SASP
SBB058178
SI-88
SMP2_000059
SMR000059146
SPBio_001032
SPBio_002400
SPECTRUM1500552
SSZ
ST50767935
Salazo-sulfapyridinum
Salazopiridazin
Salazopyridin
Salazopyrin
Salazopyrin en-tabs
Salazopyrin EN-Tabs
Salazosulfapiridina
Salazosulfapiridina [INN-Spanish]
Salazosulfapyridin
Salazosulfapyridine
Salazosulfapyridine (JP15)
Salazosulfapyridinum
Salazosulfapyridinum [INN-Latin]
Salicylazosulfapyridine
Salisulf
Sanofi Synthelabo Brand of Sulfasalazine
Sas-500
Spectrum2_001216
Spectrum3_001364
Spectrum4_000347
Spectrum5_001443
Spectrum_000998
Sulcolon
Sulfasalazin
Sulfasalazin Heyl
Sulfasalazin medac
Sulfasalazin-Heyl
Sulfasalazina
Sulfasalazina [INN-Spanish]
Sulfasalazine
Sulfasalazine (USP/INN)
Sulfasalazine FNA
Sulfasalazine Pfizer Brand
Sulfasalazine [USAN:INN]
Sulfasalazinum
Sulfasalazinum [INN-Latin]
Sulfazalazine
Sulphasalazine
TL8003811
UNII-3XC8GUZ6CB
Ucine
Ulcol
W-T Sasp Oral
WLN: T6NJ BSWMR DNUNR DQ CVQ
cMAP_000018
medac Brand of Sulfasalazine
nchembio.212-comp9
ratio Sulfasalazine
ratio-Sulfasalazine
sulfasalazine
w-t Sasp oral
15
MentholapprovedPhase 4, Early Phase 126062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
16
leucovorinapproved, NutraceuticalPhase 4, Phase 3, Phase 2323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
17
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3, Phase 2439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
18Neuroprotective AgentsPhase 4, Phase 3, Phase 2, Early Phase 11716
19Nucleic Acid Synthesis InhibitorsPhase 4, Phase 3, Phase 24962
20Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 2, Early Phase 11193
21Methylprednisolone acetatePhase 4, Phase 3, Phase 2, Early Phase 11193
22Angiogenesis InhibitorsPhase 4, Phase 24257
23Protective AgentsPhase 4, Phase 3, Phase 2, Early Phase 17443
24Rheumatoid FactorPhase 46
25Prednisolone phosphatePhase 4, Phase 3, Phase 2, Early Phase 11193
26Prednisolone hemisuccinatePhase 4, Phase 3, Phase 2, Early Phase 11193
27Prednisolone acetatePhase 4, Phase 3, Phase 2, Early Phase 11193
28Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Early Phase 123689
29Vitamin B ComplexPhase 4, Phase 3, Phase 24337
30Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 3, Phase 24443
31AntimetabolitesPhase 4, Phase 3, Phase 212054
32Antimetabolites, AntineoplasticPhase 4, Phase 3, Phase 27361
33Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 2, Early Phase 15592
34Immunosuppressive AgentsPhase 4, Phase 3, Phase 2, Phase 113086
35AntiemeticsPhase 4, Phase 3, Phase 2, Early Phase 14022
36Angiogenesis Modulating AgentsPhase 4, Phase 24185
37AnalgesicsPhase 4, Phase 3, Phase 211733
38Analgesics, Non-NarcoticPhase 4, Phase 3, Phase 26501
39AntibodiesPhase 4, Phase 3, Phase 2, Phase 16394
40Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 110956
41Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 2, Early Phase 110729
42glucocorticoidsPhase 4, Phase 3, Phase 2, Early Phase 15103
43Hormone AntagonistsPhase 4, Phase 3, Phase 2, Early Phase 113180
44Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Early Phase 113168
45ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 16394
46Gastrointestinal AgentsPhase 4, Phase 3, Phase 2, Early Phase 18402
47HormonesPhase 4, Phase 3, Phase 2, Early Phase 114415
48Folic Acid AntagonistsPhase 4, Phase 3, Phase 22257
49Dermatologic AgentsPhase 4, Phase 3, Phase 25806
50Autonomic AgentsPhase 4, Phase 3, Phase 2, Early Phase 110150

Interventional clinical trials:

(show top 50)    (show all 145)
idNameStatusNCT IDPhase
1Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic SynovitisUnknown statusNCT02060305Phase 4
2Targeting Synovitis in Early Rheumatoid ArthritisUnknown statusNCT00920478Phase 4
3Remission Induction in Very Early Rheumatoid ArthritisUnknown statusNCT00523692Phase 4
4Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid ArthritisUnknown statusNCT01282528Phase 4
5A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDsCompletedNCT01034397Phase 4
6A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.CompletedNCT00502853Phase 4
7A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging StudyCompletedNCT00396747Phase 4
8Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)CompletedNCT01098201Phase 4
9Musculoskeletal Ultrasound in Predicting Early Dose Titration With TocilizumabCompletedNCT01717859Phase 4
10Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC TrialCompletedNCT01205854Phase 4
11Bone Mineral Density Changes Under Two Tibial Components in Total Knee ArthroplastyCompletedNCT01764984Phase 4
12Prednisolone for Pain Reduction in Knee OACompletedNCT01619163Phase 4
13Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid ArthritisCompletedNCT00420927Phase 4
14Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic PolyarthritisRecruitingNCT02437461Phase 4
15A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA)RecruitingNCT02198651Phase 4
16Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid ArthritisRecruitingNCT02765074Phase 4
17Very Early Versus Delayed Etanercept in Patients With RARecruitingNCT02433184Phase 4
18The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis PatientsActive, not recruitingNCT01948388Phase 4
19Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging StudyTerminatedNCT01659242Phase 4
20A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR)TerminatedNCT01117129Phase 4
21A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDsWithdrawnNCT01878318Phase 4
22Treatment With Apremilast in Patients With Psoriatic ArthritisWithdrawnNCT02558361Phase 4
23The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis PatientsCompletedNCT01213017Phase 3
24Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the KneeCompletedNCT00604539Phase 3
25Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized StudyCompletedNCT00522184Phase 3
26A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDsCompletedNCT00996606Phase 3
27A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT00420199Phase 3
28A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler UltrasonographyCompletedNCT00767325Phase 3
29Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean FeverCompletedNCT01705756Phase 3
30Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?CompletedNCT02164214Phase 3
31Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT01235598Phase 3
32TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNFCompletedNCT00977106Phase 3
33A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT00578305Phase 3
34An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01951170Phase 3
35A Study Of RoActemra/Actemra (Tocilizumab) in Tocilizumab-Naive Patients With Rheumatoid Arthritis With Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) or Biologic TherapyCompletedNCT02001987Phase 3
36Colchicine for Symptom and Inflammation in Knee OsteoarthritisCompletedNCT02176460Phase 2, Phase 3
37Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid ArthritisCompletedNCT01244958Phase 3
38Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)RecruitingNCT02662985Phase 3
39Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive ArthralgiaRecruitingNCT02778906Phase 3
40Multicentre Canadian Study to Measure the Safety and Efficacy of RadiosynoviorthesisRecruitingNCT01615991Phase 3
41Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity DisordersRecruitingNCT02266433Phase 3
42PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)Active, not recruitingNCT02371369Phase 3
43An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural PerspectiveActive, not recruitingNCT02566967Phase 3
44Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint ReplacementsUnknown statusNCT01272830Phase 2
45Knee Osteoarthritis AND Methotrexate UseUnknown statusNCT01927484Phase 2
46Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)CompletedNCT01261429Phase 2
47Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint SynovitisCompletedNCT00678782Phase 2
48Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and EfficacyCompletedNCT00001677Phase 2
49Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT00425932Phase 2
50Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the KneeCompletedNCT01645176Phase 2

Search NIH Clinical Center for Synovitis


Cochrane evidence based reviews: synovitis

Genetic Tests for Synovitis

About this section

Genetic tests related to Synovitis:

id Genetic test Affiliating Genes
1 Synovitis27

Anatomical Context for Synovitis

About this section

MalaCards organs/tissues related to Synovitis:

36
Bone, T cells, Bone marrow, Endothelial, Neutrophil, Testes, B cells

FMA organs/tissues related to Synovitis:

17
Synovial membrane

Publications for Synovitis

About this section

Articles related to Synovitis:

(show top 50)    (show all 1222)
idTitleAuthorsYear
1
The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study. (28086960)
2017
2
Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). (28057477)
2017
3
Hereditary hemochromatosis arthropathy and Doppler ultrasound findings of synovitis. (28371912)
2017
4
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. (28081709)
2017
5
Level of agreement between three-dimensional volumetric ultrasound and real-time conventional ultrasound in the assessment of synovitis, tenosynovitis and erosions in rheumatoid arthritis patients. (27896420)
2017
6
Hoffa's pad synovitis and pain sensitisation. (27015317)
2016
7
Concordance between patient-reported joint symptoms, physician-examined arthritic signs and ultrasound-detected synovitis in rheumatoid arthritis. (27564121)
2016
8
Peripheral eosinophilia in children with transient synovitis of the hip: 7-year experience from a single centre in New Zealand. (27084779)
2016
9
Imaging for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome. (27742022)
2016
10
Associations between clinical evidence of inflammation and synovitis in symptomatic knee osteoarthritis: A substudy of the VIDEO trial. (27998036)
2016
11
Successful ledipasvira88+a88sofosbuvir treatment of active synovitis in a rheumatoid arthritis patient with hepatitis C virus-related mixed cryoglobulinemia. (27848256)
2016
12
Chemical vs. radioactive synoviorthesis for treatment of chronic haemophilic synovitis: Syrian experience. (27868370)
2016
13
Pixel-by-Pixel Arterial Spin Labeling Blood Flow Pattern Variation Analysis for Discrimination of Rheumatoid Synovitis: A Pilot Study. (27149946)
2016
14
Failed Radiation Synovectomy in Diseased Knee Joint with Missed Tuberculous Synovitis. (27651744)
2016
15
Osteonecrosis of the femoral head associated with pigmented villonodular synovitis. (27928593)
2016
16
Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA). (27775461)
2016
17
Pigmented villonodular synovitis of the knee joint in a 5-year-old girl treated with combined open and arthroscopic surgery: a case report. (26919624)
2016
18
Quantifying temporomandibular joint synovitis in children with juvenile idiopathic arthritis. (27110936)
2016
19
Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients. (27169531)
2016
20
Assessment of both articular synovitis and tenosynovitis by ultrasound is useful for evaluations of hand dysfunction in early rheumatoid arthritis patients. (27830970)
2016
21
Synovitis assessed on static and dynamic contrast-enhanced magnetic resonance imaging and its association with pain in knee osteoarthritis: A cross-sectional study. (27161058)
2016
22
Pigmented villonodular synovitis of proximal tibiofibular joint: Rare site of involvement treated with medical management. (28032093)
2016
23
Locked hip joint: an uncommon presentation of localized pigmented villonodular synovitis. (27130398)
2016
24
The preventive effect of two nutraceuticals on experimentally induced acute synovitis. (27554764)
2016
25
Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis. (27499236)
2016
26
Pigmented Villonodular Synovitis of the Knee Joint: A Case Report. (27843734)
2016
27
Synovitis of sternoclavicular and peripheral joints can be detected by ultrasound in patients with SAPHO syndrome. (27846749)
2016
28
Chronic Synovitis after Open Carpal Tunnel Decompression. (27454645)
2016
29
Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis. (27059696)
2016
30
Villonodular synovitis shoulder complicated by rotator cuff rupture. (27068614)
2016
31
Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs. (27493016)
2016
32
Active Foot Synovitis in Patients with Rheumatoid Arthritis: Patients with Foot Synovitis in Apparent Remission have Unstable Remission Status, Radiographic Progression and Worse Functional Outcomes. (26991415)
2016
33
Evaluation of a Novel Semi-Automated Ultrasound System for the Detection of Synovitis: A Prospective Study involving 45 Patients with Rheumatoid Arthritis. (27921093)
2016
34
A digital vascular malformation masquerading as synovitis. (26815764)
2016
35
Arthroscopic surgical treatment of pigmented villonodular synovitis of the elbow: case report. (27517031)
2016
36
Tumorlike Pigmented Villonodular Synovitis With Atypical Location: Appearance on 3-Phase 99mTc-MDP Bone Scan. (28005642)
2016
37
Remitting Seronegative Symmetrical Synovitis with Pitting Oedema (RS3PE) Syndrome in a Chronic Kidney Disease Patient Undzergoing Haemodialysis. (27870229)
2016
38
Synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a single centre study of a cohort of 164 patients. (26917545)
2016
39
Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis. (26820289)
2016
40
PASE and EARP questionnaires for the identification of enthesitis, synovitis, and tenosynovitis in patients with psoriasis. (27567630)
2016
41
Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis. (27933208)
2016
42
Subclinical ultrasound synovitis in a particular joint is associated with ultrasound evidence of bone erosions in that same joint in rheumatoid patients in clinical remission. (27192221)
2016
43
Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. (27659057)
2016
44
Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Associated with Myeloma and Syndrome of Inappropriate Antidiuretic Hormone Secretion in an Elderly Man. (27550802)
2016
45
Ultrasound power Doppler synovitis is associated with plasma IL-6 in established rheumatoid arthritis. (27026419)
2016
46
Pigmented villonodular synovitis mimics metastases on fluorine 18 fluorodeoxyglucose position emission tomography-computed tomography. (27190776)
2016
47
Musculoskeletal ultrasonography in the diagnosis of acute crystalline synovitis. (27439716)
2016
48
Pigmented villonodular synovitis diagnosed during revision total knee arthroplasty for flexion instability and patellar fracture. (26810732)
2016
49
Elevated synovial fluid concentration of adenosine triphosphate in dogs with osteoarthritis or sodium urate-induced synovitis of the stifle. (27432274)
2016
50
Pigmented Villonodular Synovitis: A Comprehensive Review and Proposed Treatment Algorithm. (27509331)
2016

Variations for Synovitis

About this section

Expression for genes affiliated with Synovitis

About this section
Search GEO for disease gene expression data for Synovitis.

Pathways for genes affiliated with Synovitis

About this section

Pathways related to Synovitis according to GeneCards Suite gene sharing:

(show top 50)    (show all 64)
idSuper pathwaysScoreTop Affiliating Genes
110.0IL18, IL1B
29.8IL1B, IL6, TNF
39.8IL1B, IL6, TNF
49.8IL1B, IL6, TNF
59.8IL18, IL1B, TNF
69.8IL18, IL1B, TNF
7
Show member pathways
9.7CRP, IL6, TNFSF11
89.7CXCL8, IL6, MMP1
99.7CXCL8, IL6, MMP1
109.6ICAM1, IL6, TNF
11
Show member pathways
9.5IL1B, TNF, TNFRSF11B
129.5CRP, CXCL8, IL6, TNF
139.5CXCL8, IL1B, IL6, TNF
149.5CXCL8, IL1B, IL6, TNF
15
Show member pathways
9.5CXCL8, IL1B, IL6, TNF
16
Show member pathways
9.5CXCL8, IL1B, IL6, TNF
179.5CXCL8, IL1B, IL6, TNF
18
Show member pathways
9.5IL18, IL1B, IL6, TNF
199.5IL18, IL1B, IL6, TNF
209.5IL18, IL1B, IL6, TNF
219.5ICAM1, IL18, IL1B
22
Show member pathways
9.5TNF, TNFRSF11B, TNFSF11
239.5CD163, IL1B, IL6, TNF
24
Show member pathways
9.4CXCL8, IL18, IL1B, IL6
25
Show member pathways
9.4MMP1, MMP13, MMP3, TNFSF11
269.4CXCL8, MMP1, MMP13, MMP3
279.3IL1B, TNF, TNFRSF11B, TNFSF11
289.2IL18, IL1B, TNF, VCAM1
299.2CXCL8, IL18, IL1B, IL6, TNF
30
Show member pathways
9.2CXCL8, IL18, IL1B, IL6, TNF
31
Show member pathways
9.2CXCL8, IL18, IL1B, IL6, TNF
329.2CXCL8, ICAM1, VCAM1
339.2MMP1, MMP3, SELE
34
Show member pathways
9.1CRP, ICAM1, IL1B, IL6, TNF
35
Show member pathways
9.1MMP1, MMP13, MMP3, PRSS2, TNF
369.1CXCL8, IL6, SELE
379.1CXCL8, IL1B, IL1RN, IL6, TNF
389.1ICAM1, IL1B, TNF, VCAM1
399.1CXCL8, ICAM1, IL1B, IL6, TNF
40
Show member pathways
9.1CXCL8, ICAM1, IL1B, IL6, TNF
419.1ICAM1, IL6, TNF, VCAM1
429.1ICAM1, IL6, TNF, VCAM1
439.0IL1B, IL6, TNF, TNFRSF11B, TNFSF11
449.0CXCL8, IL18, IL1B, IL6, TNF, TNFSF11
458.9IL1B, IL1RN, TNF, TNFSF11, VCAM1
46
Show member pathways
8.8CXCL8, IL18, IL1B, IL1RN, IL6, TNF
47
Show member pathways
8.7ICAM1, TNFRSF11B, TNFSF11, VCAM1
48
Show member pathways
8.7CXCL8, IL1B, IL6, MMP1, MMP13, MMP3
498.7ICAM1, SELE, VCAM1
508.5CXCL8, ICAM1, IL1B, TNF, TNFSF11, VCAM1

GO Terms for genes affiliated with Synovitis

About this section

Cellular components related to Synovitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular matrixGO:00310129.9COMP, MMP1, MMP13, MMP3, PRSS2
2external side of plasma membraneGO:00098979.5CD163, ICAM1, IL6, TNF, VCAM1
3proteinaceous extracellular matrixGO:00055788.9COMP, MMP1, MMP13, MMP3, TNFRSF11B
4extracellular regionGO:00055766.2CD163, COMP, CRP, CXCL8, IL18, IL1B
5extracellular spaceGO:00056155.5COMP, CRP, CXCL8, ICAM1, IL18, IL1B

Biological processes related to Synovitis according to GeneCards Suite gene sharing:

(show all 46)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.8IL6, TNF
2positive regulation of calcidiol 1-monooxygenase activityGO:006055910.8IL1B, TNF
3positive regulation of chemokine biosynthetic processGO:004508010.8IL1B, TNF
4positive regulation of fever generationGO:003162210.8IL1B, TNF
5positive regulation of heterotypic cell-cell adhesionGO:003411610.8IL1B, TNF
6regulation of establishment of endothelial barrierGO:190314010.7IL1B, TNF
7positive regulation of granulocyte macrophage colony-stimulating factor productionGO:003272510.7IL18, IL1B
8growth plate cartilage developmentGO:000341710.6COMP, MMP13
9defense response to Gram-positive bacteriumGO:005083010.6CRP, IL6, TNF
10positive regulation of T-helper 2 cell differentiationGO:004563010.5IL18, IL6
11cellular response to nutrient levelsGO:003166910.5ICAM1, IL6
12cellular response to organic cyclic compoundGO:007140710.5IL18, IL1B, TNF
13negative regulation of lipid storageGO:001088810.5CRP, IL6, TNF
14negative regulation of interleukin-1-mediated signaling pathwayGO:200066010.5IL1RN, IL6
15positive regulation of leukocyte adhesion to vascular endothelial cellGO:190499610.5ICAM1, TNF
16positive regulation of interleukin-6 productionGO:003275510.5IL1B, IL6, TNF
17positive regulation of JNK cascadeGO:004633010.5IL1B, TNF, TNFSF11
18lipopolysaccharide-mediated signaling pathwayGO:003166310.5IL18, IL1B, TNF
19positive regulation of interferon-gamma productionGO:003272910.5IL18, IL1B, TNF
20acute-phase responseGO:000695310.5CD163, CRP, IL6
21positive regulation of NF-kappaB import into nucleusGO:004234610.4IL18, IL1B, TNF
22negative regulation of bone resorptionGO:004577910.4IL6, TNFRSF11B
23positive regulation of smooth muscle cell proliferationGO:004866110.4IL18, IL6, TNF
24cellular response to interleukin-1GO:007134710.2CXCL8, ICAM1, IL6
25response to glucocorticoidGO:005138410.2IL1RN, IL6, TNF
26membrane to membrane dockingGO:002261410.2ICAM1, VCAM1
27positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.2IL1B, IL6, TNF, TNFSF11
28positive regulation of protein kinase B signalingGO:005189710.1IL18, IL6, TNF, TNFSF11
29positive regulation of T cell proliferationGO:004210210.1IL1B, IL6, VCAM1
30collagen catabolic processGO:003057410.1MMP1, MMP13, MMP3, PRSS2
31extracellular matrix disassemblyGO:002261710.1MMP1, MMP13, MMP3, PRSS2
32sequestering of triglycerideGO:003073010.1IL1B, TNF
33cellular response to lipopolysaccharideGO:007122210.1CXCL8, ICAM1, IL6, TNF
34regulation of cell adhesionGO:003015510.0CXCL8, ICAM1, IL18
35positive regulation of nitric oxide biosynthetic processGO:004542910.0ICAM1, IL1B, IL6, TNF
36calcium-mediated signalingGO:00197229.9CXCL8, SELE, TNFSF11
37positive regulation of NF-kappaB transcription factor activityGO:00510929.8ICAM1, IL1B, IL6, TNF, TNFSF11
38cellular response to tumor necrosis factorGO:00713569.7CXCL8, ICAM1, IL6, VCAM1
39leukocyte tethering or rollingGO:00509019.6SELE, TNF, VCAM1
40heterophilic cell-cell adhesion via plasma membrane cell adhesion moleculesGO:00071579.4ICAM1, SELE, VCAM1
41leukocyte cell-cell adhesionGO:00071599.4ICAM1, SELE, VCAM1
42extracellular matrix organizationGO:00301989.3COMP, ICAM1, TNF, TNFRSF11B, VCAM1
43leukocyte migrationGO:00509009.2ICAM1, IL1B, MMP1, SELE, TNF
44immune responseGO:00069558.1CXCL8, IL18, IL1B, IL1RN, IL6, PRG4
45response to lipopolysaccharideGO:00324967.7ICAM1, IL1B, IL6, SELE, TNFRSF11B, VCAM1
46inflammatory responseGO:00069547.7CD163, CRP, CXCL8, IL18, IL1B, IL1RN

Molecular functions related to Synovitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1metalloendopeptidase activityGO:00042229.9MMP1, MMP13, MMP3, PRSS2
2calcium ion bindingGO:00055099.5COMP, CRP, MMP1, MMP13, MMP3, PRSS2
3serine-type endopeptidase activityGO:00042529.3MMP1, MMP13, MMP3, PRSS2
4cytokine activityGO:00051258.7CXCL8, IL18, IL1B, IL1RN, IL6, TNF

Sources for Synovitis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet